Polypharmacy in multiple sclerosis: More is not necessarily better

Mult Scler. 2023 Jan;29(1):3-5. doi: 10.1177/13524585221129964. Epub 2022 Oct 14.

Authors

Dennis Bourdette¹, Megan Herink²

Affiliations

¹ Department of Neurology, Oregon Health & Science University, Portland, OR, USA.
² College of Pharmacy, Oregon Health & Science University/Oregon State University, Portland, OR, USA.

PMID: 36239156
DOI: 10.1177/13524585221129964

No abstract available

Publication types

Editorial

MeSH terms

Humans
Multiple Sclerosis* / drug therapy
Polypharmacy